Omnitura Therapeutics Inc.

www.omnitura.com

Omnitura Therapeutics is a clinical stage company that is commercializing Aneustat™, the world's first multivalent immuno-oncology drug candidate. Aneustat™ has successfully completed a phase I/IIa clinical trial in cancer patients and is now entering phase II clinical trials for prostate cancer. For more information, please visit www.omnitura.com.

Read more

Reach decision makers at Omnitura Therapeutics Inc.

Lusha Magic

Free credit every month!

Omnitura Therapeutics is a clinical stage company that is commercializing Aneustat™, the world's first multivalent immuno-oncology drug candidate. Aneustat™ has successfully completed a phase I/IIa clinical trial in cancer patients and is now entering phase II clinical trials for prostate cancer. For more information, please visit www.omnitura.com.

Read more
icon

Country

icon

State

California

icon

City (Headquarters)

Burlingame

icon

Employees

1-10

icon

Founded

2001

icon

Estimated Revenue

$5,000,000 to $10,000,000

icon

Social

  • icon

Employees statistics

View all employees

Potential Decision Makers

  • Chief Operations Officer

    Email ****** @****.com
    Phone (***) ****-****

Reach decision makers at Omnitura Therapeutics Inc.

Free credits every month!

My account

Sign up now to uncover all the contact details